Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
VANCOUVER, British Columbia, July 18, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, disclosed that its licensee, Talon Therapeutics, Inc. (OTCBB:TLON), announced that it will be acquired by Spectrum Pharmaceuticals, Inc. (Nasdaq:SPPI).
Help employers find you! Check out all the jobs and post your resume.
